Harras Pharma
Harras Pharma HOME Company Export Contact
Service Telephone: +49 (89) 747 367 0
Deutsch
Espanol

Harras Pharma
Harras Pharma HOME Company Export Contact
Service Telephone: +49 (89) 747 367 0
Deutsch
Espanol

Traumaplant® Cream

The percutaneous antitraumatic

 

 

  • for bruises and sprains, joint and muscle pain
  • relieves pain, reduces swelling and inflammation
  • additional wound healing, for open and blunt injuries
  • highly concentrated active ingredient from
    medical comfrey (Trauma-Comfrey)

 

 

 

 

 

Video sehen
ver video

  Composition    Clinical Trials 

 

 
  Comfrey (Symphytum) is traditionally known as one of the most valuable medicinal plants and was already used in ancient times due to its antiinflammatory and wound-healing effects for fractures, sprains, bruises and even burns.
Its antiphlogistic, pain relieving, anti-exudative and wound-healing effects have meanwhile been confirmed by numerous scientific evidence.

 

Composition

Symphytum concentrate
(active ingredient)

10.0 g

(ex herba symphyti recente

25.0 g)

Emulsion cream base                 ad 100.0 g

The active components in Traumaplant®
The active ingredients contained in Traumaplant® cream are taken from freshly harvested symphytum blossoms and leaves, a specially cultivated medical comfrey (Symphytum x uplandicum NYMAN) -  “Trauma-Comfrey”. 

By means of a particulary careful process,
the pharmacologically active, high dosage and standardized ingredients in Traumaplant® are isolated from the
freshly pressed plant sap.

Choline, rosmarinic acid derivates and allantoin provide the antiphlogistic, antiexudative and wound-healing effects.

In intermediary metabolism, choline is the central building block for various biosynthetic processes and achieves vasodilatation through the parasympathetic nerve endings and therefore, improves perfusion in the inflamed tissue.

Inflammatory exudates and metabolic products are removed. Acting as a vasoactive substance with capillary membrane-sealing properties, choline is the most important anti-exudative ingredient among the active components in Traumaplant®.

Besides anti-exudative properties, rosmarinic acid derivates possesses an excellent antiphlogistic effect and inhibits the formation of inflammation mediators.

Allantoin - an active component in Traumaplant® - stimulates cell proliferation and promotes regeneration of damaged tissue. It is, therefore, responsible for the effects which promote granulation and the wound-healing action of Traumaplant® cream.


 

Traumaplant® - the percutaneous antitraumatic
The various pharmacological properties
of the ingredients in Traumaplant®

  • antiphlogistic
  • anti-exudative
  • wound healing
  • analgetic

are responsible for the extensive and reliable effects of this antitraumatic medication in cases of painful diseases of joints, sports injuries, sprains, bruises, slow-healing wounds and inflammatory symptoms associated with disorders of the muscles, tendons and joints.

The emulsion system of the cream base has been highly developed from both a galenical and cosmetic point of view.

Traumaplant® acts directly on superficial wounds and, after percutaneous absorption, on deeper lying injuries - especially in cases of deeper inflammations and exudates resulting from blunt injuries.

Traumaplant® provides topical treatment without systemic side effects.

Successful treatment using Traumaplant® provides

  • rapid decrease in swelling and inflammation
  • pain relief
  • reduces feeling of tension
  • additional wound healing
    thus, Traumaplant® is reliable and effective in cases of both open and blunt injuries.
 

Clinical Trials
with Traumaplant®
- Information for Experts -

UEBELHACK et al. (2014):
Muscle pain related to overload-induced muscle soreness

KUCERA et al. (2012):
Acute and chronic back pain

BARNA et al. (2012):
Wound healing in children
(Double-blind study)

SCHMIDT et al. (2011):
Children with acute, blunt traumata

GUTH A. (2009):
Functional disorders of the
cervical column

M. BARNA et al. (2007):
Wound healing
(Double blind study)

M. KUCERA et al. (2005):
Muscle pain (myalgia)
(Double blind study)


M. KUCERA et al. (2004):
Accidental and sports injuries (Ankle distortion)
(Double blind study)

M. KUCERA, (2000):
Muscular pain, functional
disturbances of the locomotor system

G. MAYER (1993): 
Acute Supraspinatus Tendon Syndrome (Painful shoulder)

G. MAYER (1992):
Contusions and Distortions of the Knee Joint

H. HESS (1991):
Sports Injuries of the Knee Joint

G. MAYER (1991):
Acute lateral Distortions of the Ancle Joint

R. NIEDNER (1989):
Open shallow wounds



 

 

 

 

Indications:

Bruises and sprains (sports and accidental injuries), joint and muscle pain, slow healing wounds.


Application and Dosage:

For external applicaton. If not otherwise instructed, the cream should be applied
up to several times daily to the afflicted region. Especially suitable for cream bandages.


Contra-Indications:

No contra-indications are known.

Traumaplant® is free of problematic pyrrolicidine alcaloides (detection limit 0,1 ppm, officially fixed safety limit 10 mg pyrrolicidine alcaloides / day)


Side effects:

In rare cases erythema (reddening of the skin) may occur, especially in patients with extremely sensitive skin or with an allergic tendency to a component of Traumaplant® cream.

Interaction with other drugs:

No interactions with other drugs are known.
Presentation:

Traumaplant® cream

25g

Traumaplant® cream

50 g

Traumaplant® cream

100g

 

 

 
 
© HARRAS PHARMA CURARINA Arzneimittel GmbH • 2014